[ Price : $8.95]
FDA accepts for review an Alnylam Pharmaceuticals supplemental NDA for vutrisiran, an investigational RNAi therapeutic in developm...[ Price : $8.95]
FDA approves a BridgeBio Pharma NDA for Attruby (acoramidis), a near-complete stabilizer of transthyretin for treating adults with...[ Price : $8.95]
Cassava Sciences discontinues the development of its Alzheimers disease drug simufilam after announcing disappointing topline data...[ Price : $8.95]
Merck stops early its Phase 3 ZENITH study evaluating Winrevair (sotatercept-csrk) in adults with pulmonary arterial hypertension ...[ Price : $8.95]
President-elect Donald Trump names Johns Hopkins surgeon and public policy researcher Marty Makary as his nomination to be the nex...[ Price : $8.95]
FDA issues a final guidance entitled Transitional Enforcement Policy for Ethylene Oxide Sterilization Facility Changes for Class 3...[ Price : $8.95]
FDA approves a Zimmer Biomet PMA supplement for its Oxford Cementless Partial Knee.